We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Seer Inc (SEER) USD0.00001 A

Sell:$1.57 Buy:$1.58 Change: $0.005 (0.32%)
NASDAQ:0.32%
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
Sell:$1.57
Buy:$1.58
Change: $0.005 (0.32%)
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
Sell:$1.57
Buy:$1.58
Change: $0.005 (0.32%)
Market closed |  Prices as at close on 21 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product Suite (Proteograph), is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. Proteograph leverages its engineered nanoparticle (NP) technology to provide large-scale access to the proteome. Its engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide level, including protein variants. It is focused on adoption of the Proteograph with customers in the proteomics and genomics markets. The Company is initially focused on research applications for the Proteograph product suite and is selling and marketing the Proteograph for research use only (RUO).

Contact details

Address:
3800 Bridge Parkway, Suite 102
REDWOOD CITY
94065
United States
Telephone:
+1 (650) 4530000
Website:
https://seer.bio/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SEER
ISIN:
US81578P1066
Market cap:
$105.31 million
Shares in issue:
63.83 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Omid Farokhzad
    Chairman of the Board, Chief Executive Officer, Co-Founder
  • David Horn
    President, Chief Financial Officer, Treasurer
  • Elona Kogan
    General Counsel, Company Secretary, Chief Legal Officer
  • Scott Thomas
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.